Selection of antibodies for intracellular function using a two-hybrid in vivo system.
about
Intrabody and Parkinson's diseaseDirected evolution of single-chain Fv for cytoplasmic expression using the beta-galactosidase complementation assay results in proteins highly susceptible to protease degradation and aggregationIntracellular targeting with engineered proteinsTumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RASFunctional inactivation of the conserved Sem1p in yeast by intrabodies.Intracellular stability of anti-caspase-3 intrabodies determines efficacy in retargeting the antigen.Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity.Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras.Direct in vivo screening of intrabody libraries constructed on a highly stable single-chain framework.De novo production of diverse intracellular antibody libraries.Recombinant antibodies against subcellular fractions used to track endogenous Golgi protein dynamics in vivo.Mapping the epitope of an inhibitory monoclonal antibody to the C-terminal DNA-binding domain of HIV-1 integrase.Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors.Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.Conjugative transfer can be inhibited by blocking relaxase activity within recipient cells with intrabodies.A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm.Engineering antibody fragments to fold in the absence of disulfide bonds.Selection of complementary single-variable domains for building monoclonal antibodies to native proteinsTwo-state selection of conformation-specific antibodiesVersatile selection technology for intracellular protein-protein interactions mediated by a unique bacterial hitchhiker transport mechanismmRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid proteinProtocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture.Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody.Generation of high-affinity fully human anti-interleukin-8 antibodies from its cDNA by two-hybrid screening and affinity maturation in yeastCharacterization of single chain antibody targets through yeast two hybridSingle domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domainBeyond natural antibodies: the power of in vitro display technologies.Targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodiesDirected evolution of a fluorogen-activating single chain antibody for function and enhanced brightness in the cytoplasmDesign and selection of a camelid single-chain antibody yeast two-hybrid library produced de novo for the cap protein of porcine circovirus type 2 (PCV2)Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformationIntracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy.Selection of intracellular single-domain antibodies targeting the HIV-1 Vpr protein by cytoplasmic yeast two-hybrid system.p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.Growth signalobody selects functional intrabodies in the mammalian cytoplasm.Assessment of antibody library diversity through next generation sequencing and technical error compensation.Immunosympathectomy as the first phenotypic knockout with antibodies.Intrabody strategies for the treatment of human papillomavirus-associated disease.
P2860
Q24653530-EE73AB73-8C81-44D9-8CCC-7C43636BB804Q24803075-74992E5C-275B-4BC5-BF59-398806B02E24Q26740106-889BEEC5-9E91-48BF-BB16-F3622F415730Q27645826-68BB0B28-8B94-423F-B238-E0246DD2CC62Q27938997-542E1433-F04F-43D3-8985-E9FB37E0FE79Q30683029-FA1D2400-6C4B-4CF4-809C-A194DE2C0120Q30749300-386272E3-E0B4-45B7-A9CA-A56E715A7A46Q30838641-EB8028AD-6DC4-4472-A5B5-3D3F0E196A2BQ30845963-E4FB66AC-1E88-4B62-B83D-C52C00909DC1Q30887786-5B2E6E31-7F5A-45F4-A89F-52A7DD0F532AQ31025423-9918D06D-444E-4AD3-AE13-46AA36133D4AQ31035885-2941F796-4648-40C4-AD7F-276B675758B2Q31155271-ECC8C434-B172-420B-8ADC-8C73309BA58CQ33186341-B8447CDB-E4EA-4CCC-A77C-A98A10714D03Q33204254-1908CD87-8856-433F-A40A-6941499520F9Q33266305-ACF73D63-A0DE-40A0-998F-9A1D605B17ADQ33307001-404252D6-996D-46A9-B8EA-40FB92A33A9DQ33403805-47715AD6-43A7-47AB-A9BB-1C364EBA7F2AQ33408086-F7E5291E-9DB8-43F6-B3F5-52DC7EFE4B16Q33408112-B0F8D69D-A62C-4B70-815A-EBC5160A38CEQ33411263-A26D79CF-764A-47EB-8A09-14547295576DQ33429766-1172D5A9-5604-48F8-BA0E-CD8E4798DCDFQ33522558-6B254CD2-4E3A-4827-ADC1-781C53E7CF25Q33580733-CE2D30F7-E801-44BD-AD63-05AC21BC1C56Q33662280-58D4C5DE-3660-4125-8F45-0C3F739B0C33Q33667675-97563D07-8A4D-448D-9DB7-347FCFB4712AQ33729971-111A61BB-2762-40DB-89B4-9746C2BB9687Q33841864-BCB5F7C8-E033-4564-B42C-1B900DA632FCQ34317634-DC6FE380-82AE-4503-A55E-F5ACF49E8442Q34513726-2DC84A5B-BD64-45EE-A26C-CB86543CE98DQ34612959-34F5C480-EE72-4185-B456-7BAAE52CA8DFQ34775170-9024A911-94DB-44A0-9937-8A8E8DEBCB3AQ35418257-C81713C1-1F78-444A-BA6D-E6A1EB94A115Q35462984-32A4A34B-B6D9-4E45-B0DA-5D1D33881FC0Q35641069-E1868C7E-A9B9-48BC-A59E-D8F84628340BQ35797390-5440D583-D992-486E-81CF-638730A40C52Q35863642-4410D26C-6639-4644-A593-19060B04B922Q36372120-3E249061-719A-4445-B678-986A1ECECE1BQ36729840-9348721E-E857-4198-A447-99C6C16FC625Q36810292-E055BD09-C9C1-4353-BA87-CF43C003C8EA
P2860
Selection of antibodies for intracellular function using a two-hybrid in vivo system.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Selection of antibodies for intracellular function using a two-hybrid in vivo system.
@ast
Selection of antibodies for intracellular function using a two-hybrid in vivo system.
@en
type
label
Selection of antibodies for intracellular function using a two-hybrid in vivo system.
@ast
Selection of antibodies for intracellular function using a two-hybrid in vivo system.
@en
prefLabel
Selection of antibodies for intracellular function using a two-hybrid in vivo system.
@ast
Selection of antibodies for intracellular function using a two-hybrid in vivo system.
@en
P2093
P2860
P356
P1476
Selection of antibodies for intracellular function using a two-hybrid in vivo system.
@en
P2093
P2860
P304
11723-11728
P356
10.1073/PNAS.96.21.11723
P407
P577
1999-10-01T00:00:00Z